TOMCAT: Non-invasive Measurement of Cerebral Dynamic Autoregulation
Study Details
Study Description
Brief Summary
The overall objective of this study is to evaluate the use of diffuse correlation spectroscopy to non-invasively measure dynamic cerebral autoregulation in subjects with vascular risk factors. Optical cerebral blood flow measurements will be correlated with changes in arterial blood pressure to assess how CBF is maintained in response to changes in ABP, and will be compared to transcranial doppler reference measurements.
Condition or Disease | Intervention/Treatment | Phase |
---|---|---|
|
N/A |
Study Design
Arms and Interventions
Arm | Intervention/Treatment |
---|---|
Experimental: Intervention We will measure dCA with both TCD and DCS during acute changes in mean arterial pressure using thigh cuff deflation techniques in vascular risk factor subjects. Measurements will be compared between TCD and DCS in order to validate DCS as a tool to measure dCA in this population. |
Device: Thigh Cuff
|
Outcome Measures
Primary Outcome Measures
- dCA Measurement During Acute Changes in Mean Arterial Pressure, TCD [1.5 hours]
Rate of Regulation, measured using transcranial doppler. Rate of regulation (ROR) is calculated as follows: ROR = (change in relative cerebrovascular resistance / change in time) / maximum fractional decrease in blood pressure due to thigh cuff deflation.
- dCA Measurement During Acute Changes in Mean Arterial Pressure, Optical [1.5 hours]
Rate of Regulation, measured using diffuse correlation spectroscopy. Rate of regulation (ROR) is calculated as follows: ROR = (change in relative cerebrovascular resistance / change in time) / maximum fractional decrease in blood pressure due to thigh cuff deflation.
Other Outcome Measures
- Linear Relationship Between Rate of Regulation Measured Using TCD and Optics [1.5 hours]
Linear relationship between Rate of Regulation measured using TCD and Optics, expressed as slope of linear fit
Eligibility Criteria
Criteria
Inclusion Criteria:
-
Age greater than or equal to 50 years
-
Positive history of at least one of the following vascular disk factors: hypertension, diabetes, hyperlipidemia, coronary artery disease, atrial fibrillation, prior myocardial infarct, transient ischemic attack, or history of smoking
Exclusion Criteria:
- Vascular risk factor subjects:
-
Pregnant women
-
Prisoners
-
Prior neurosurgical procedure or traumatic brain injury, including hemicraniectomy or other skull defect
-
Prior history of ischemic or hemorrhagic stroke
-
Prior lower extremity amputation
-
Peripheral vascular disease
Contacts and Locations
Locations
Site | City | State | Country | Postal Code | |
---|---|---|---|---|---|
1 | Hospital of the University of Pennsylvania | Philadelphia | Pennsylvania | United States | 19104 |
Sponsors and Collaborators
- University of Pennsylvania
Investigators
None specified.Study Documents (Full-Text)
More Information
Publications
None provided.- 821705
Study Results
Participant Flow
Recruitment Details | |
---|---|
Pre-assignment Detail |
Arm/Group Title | Intervention |
---|---|
Arm/Group Description | We will measure dynamic cerebral autoregulation (dCA) with both transcranial doppler (TCD) and diffuse correlation spectroscopy (DCS) during acute changes in mean arterial pressure using thigh cuff deflation techniques in vascular risk factor subjects. Measurements will be compared between TCD and DCS in order to validate DCS as a tool to measure dCA in this population. |
Period Title: Overall Study | |
STARTED | 21 |
COMPLETED | 21 |
NOT COMPLETED | 0 |
Baseline Characteristics
Arm/Group Title | Intervention |
---|---|
Arm/Group Description | We will measure dCA with both TCD and DCS during acute changes in mean arterial pressure using thigh cuff deflation techniques in vascular risk factor subjects. Measurements will be compared between TCD and DCS in order to validate DCS as a tool to measure dCA in this population. |
Overall Participants | 21 |
Age (years) [Median (Inter-Quartile Range) ] | |
Median (Inter-Quartile Range) [years] |
31
|
Sex: Female, Male (Count of Participants) | |
Female |
9
42.9%
|
Male |
12
57.1%
|
Race and Ethnicity Not Collected (Count of Participants) |
Outcome Measures
Title | dCA Measurement During Acute Changes in Mean Arterial Pressure, TCD |
---|---|
Description | Rate of Regulation, measured using transcranial doppler. Rate of regulation (ROR) is calculated as follows: ROR = (change in relative cerebrovascular resistance / change in time) / maximum fractional decrease in blood pressure due to thigh cuff deflation. |
Time Frame | 1.5 hours |
Outcome Measure Data
Analysis Population Description |
---|
21 subjects consented, hemodynamic monitoring possible in 18. 1 subject did not tolerate,data acquisition was unsuccessful in 2. In 3 subjects, the pressure algorithm to isolate cerebral blood flow(CBF) was unsuccessful. In 4 subjects, BP did not decrease following cuff deflation due to technical issues leaving 11 subjects in the final analysis |
Arm/Group Title | Intervention |
---|---|
Arm/Group Description | We will measure dCA with both TCD and DCS during acute changes in mean arterial pressure using thigh cuff deflation techniques in vascular risk factor subjects. Measurements will be compared between TCD and DCS in order to validate DCS as a tool to measure dCA in this population. |
Measure Participants | 11 |
Number (95% Confidence Interval) [per second] |
0.262
|
Title | dCA Measurement During Acute Changes in Mean Arterial Pressure, Optical |
---|---|
Description | Rate of Regulation, measured using diffuse correlation spectroscopy. Rate of regulation (ROR) is calculated as follows: ROR = (change in relative cerebrovascular resistance / change in time) / maximum fractional decrease in blood pressure due to thigh cuff deflation. |
Time Frame | 1.5 hours |
Outcome Measure Data
Analysis Population Description |
---|
21 subjects in the study, but hemodynamic monitoring was only possible in 18. 1 subject did not tolerate, and data acquisition was unsuccessful in 2. In 3 subjects, the pressure algorithm to isolate CBF was unsuccessful. In 4 subjects, BP did not decrease following cuff deflation due to technical issues leaving 11 subjects in the final analysis |
Arm/Group Title | Intervention |
---|---|
Arm/Group Description | We will measure dCA with both TCD and DCS during acute changes in mean arterial pressure using thigh cuff deflation techniques in vascular risk factor subjects. Measurements will be compared between TCD and DCS in order to validate DCS as a tool to measure dCA in this population. |
Measure Participants | 11 |
Number (95% Confidence Interval) [per second] |
0.278
|
Title | Linear Relationship Between Rate of Regulation Measured Using TCD and Optics |
---|---|
Description | Linear relationship between Rate of Regulation measured using TCD and Optics, expressed as slope of linear fit |
Time Frame | 1.5 hours |
Outcome Measure Data
Analysis Population Description |
---|
[Not Specified] |
Arm/Group Title | Intervention |
---|---|
Arm/Group Description | We will measure dCA with both TCD and DCS during acute changes in mean arterial pressure using thigh cuff deflation techniques in vascular risk factor subjects. Measurements will be compared between TCD and DCS in order to validate DCS as a tool to measure dCA in this population. |
Measure Participants | 11 |
Number [slope] |
0.96
|
Adverse Events
Time Frame | Duration of study, which was approximately 6 months. | |
---|---|---|
Adverse Event Reporting Description | ||
Arm/Group Title | Intervention | |
Arm/Group Description | We will measure dCA with both TCD and DCS during acute changes in mean arterial pressure using thigh cuff deflation techniques in vascular risk factor subjects. Measurements will be compared between TCD and DCS in order to validate DCS as a tool to measure dCA in this population. | |
All Cause Mortality |
||
Intervention | ||
Affected / at Risk (%) | # Events | |
Total | 0/21 (0%) | |
Serious Adverse Events |
||
Intervention | ||
Affected / at Risk (%) | # Events | |
Total | 0/21 (0%) | |
Other (Not Including Serious) Adverse Events |
||
Intervention | ||
Affected / at Risk (%) | # Events | |
Total | 0/21 (0%) |
Limitations/Caveats
More Information
Certain Agreements
Principal Investigators are NOT employed by the organization sponsoring the study.
There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
Results Point of Contact
Name/Title | Michael Mullen |
---|---|
Organization | University of Pennsylvania |
Phone | 215-662-3339 |
mmullen@pennmedicine.upenn.edu |
- 821705